VeriSilicon(688521)

Search documents
芯原微电子申请一种处理器及数据分配方法以及电子设备专利,提高处理器的处理性能
Sou Hu Cai Jing· 2025-07-28 01:06
天眼查资料显示,芯原微电子(南京)有限公司,成立于2020年,位于南京市,是一家以从事软件和信 息技术服务业为主的企业。企业注册资本10000万人民币。通过天眼查大数据分析,芯原微电子(南 京)有限公司专利信息139条,此外企业还拥有行政许可3个。 芯原微电子(上海)股份有限公司,成立于2001年,位于上海市,是一家以从事软件和信息技术服务业 为主的企业。企业注册资本49991.1232万人民币。通过天眼查大数据分析,芯原微电子(上海)股份有 限公司共对外投资了20家企业,参与招投标项目68次,财产线索方面有商标信息57条,专利信息233 条,此外企业还拥有行政许可45个。 金融界2025年7月28日消息,国家知识产权局信息显示,芯原微电子(南京)有限公司、芯原微电子 (上海)股份有限公司、芯原微电子(海南)有限公司、芯原微电子(成都)有限公司、芯原科技(上 海)有限公司申请一项名为"一种处理器及数据分配方法以及电子设备"的专利,公开号 CN120380456A,申请日期为2025年03月。 专利摘要显示,本申请涉及一种处理器及数据分配方法以及电子设备。该处理器包括:集群分配器和多 个处理集群;每个处理集群包 ...
芯原股份戴伟民:汽车智驾与AI眼镜成为全球半导体产业新蓝海
news flash· 2025-07-25 08:34
《科创板日报》25日讯,"2025中国科创领袖大会暨科创板开市六周年"今日开幕,芯原股份创始人、董 事长兼总裁戴伟民发表主题演讲。他表示,芯原股份不仅见证了中国半导体产业的发展,也代表了中国 芯片企业从本土走向国际化。科创板帮助芯原股份从中国半导体IP龙头,成长为ASIC龙头。目前,芯 原股份半导体IP授权业务销售收入全球排名第8,中国排名第1,IP种类位居全球前二,集成了芯原NPU IP 的人工智能(AI)类芯片已在全球范围内出货超过1亿颗。汽车智驾与AI眼镜将成为全球半导体产业 的新蓝海。(记者 郭辉) 芯原股份戴伟民:汽车智驾与AI眼镜成为全球半导体产业新蓝海 ...
芯原股份(688521)7月25日主力资金净流入1.22亿元
Sou Hu Cai Jing· 2025-07-25 07:34
天眼查商业履历信息显示,芯原微电子(上海)股份有限公司,成立于2001年,位于上海市,是一家以从 事软件和信息技术服务业为主的企业。企业注册资本49991.1232万人民币,实缴资本36900万人民币。 公司法定代表人为WAYNE WEI-MING DAI。 通过天眼查大数据分析,芯原微电子(上海)股份有限公司共对外投资了20家企业,参与招投标项目68 次,知识产权方面有商标信息57条,专利信息233条,此外企业还拥有行政许可45个。 来源:金融界 金融界消息 截至2025年7月25日收盘,芯原股份(688521)报收于93.03元,上涨6.89%,换手率3.1%, 成交量15.48万手,成交金额13.96亿元。 资金流向方面,今日主力资金净流入1.22亿元,占比成交额8.76%。其中,超大单净流入6481.18万元、 占成交额4.64%,大单净流入5751.02万元、占成交额4.12%,中单净流出流出6056.06万元、占成交额 4.34%,小单净流出6176.13万元、占成交额4.42%。 芯原股份最新一期业绩显示,截至2025一季报,公司营业总收入3.90亿元、同比增长22.49%,归属净利 润2203 ...
芯原股份(688521) - 关于首次回购股份暨回购股份方案实施完成的公告
2025-07-22 09:47
证券代码:688521 证券简称:芯原股份 公告编号:2025-039 芯原微电子(上海)股份有限公司 关于首次回购股份暨回购股份方案实施完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 回购方案首次披露日 | 2025/7/15 | | --- | --- | | 回购方案实施期限 | 年 月 日~2026 年 月 日 2025 7 14 7 13 | | 预计回购金额 | 2,300.00万元~3,000.00万元 | | 回购价格上限 | 120元/股 | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 实际回购股数 | 28.70万股 | | 实际回购股数占总股本比例 | 0.0546% | | 实际回购金额 | 2,483.19万元 | | 实际回购价格区间 | 85.80元/股~87.00元/股 | 一、 回购审批情况和回购方案内容 公司于 2025 年 7 月 14 日召开第二届董事会第 ...
科创芯片ETF(588200)连续10天净流入,源杰科技涨超11%领涨成分股
Sou Hu Cai Jing· 2025-07-22 02:37
Group 1: ETF Performance - The Sci-Tech Chip ETF has a turnover rate of 1.3% and a transaction volume of 410 million yuan [3] - As of July 21, the ETF's latest scale reached 31.565 billion yuan, marking a six-month high and ranking first among comparable funds [3] - The ETF's latest share count is 20.644 billion shares, also a six-month high and leading among comparable funds [3] - Over the past 10 days, the ETF has seen continuous net inflows, with a maximum single-day net inflow of 761 million yuan, totaling 3.097 billion yuan [3] - The leveraged funds are actively investing, with a net financing amount of 23.377 million yuan this month and a latest financing balance of 1.855 billion yuan [3] - The ETF's net value has increased by 28.75% over the past two years, ranking 271 out of 2237 index equity funds, placing it in the top 12.11% [3] - Since its inception, the ETF's highest monthly return was 25.18%, with the longest consecutive monthly gains being 4 months and a maximum increase of 36.01% [3] Group 2: Semiconductor Industry Insights - Meta's founder Mark Zuckerberg announced plans for Meta to become the first to invest in a 1GW computing power supercluster laboratory, with expansion plans to 5GW in the coming years [4] - NVIDIA's CEO Jensen Huang announced two significant developments during his visit to China: approval for H20 chip sales to China and the launch of a custom RTX PRO GPU for the Chinese market [4] - Tianfeng Securities projects optimistic growth for the global semiconductor industry through 2025, driven by AI and ongoing domestic substitution efforts [4] - The second quarter showed strong performance forecasts across various semiconductor segments, with expectations for a robust third quarter [4] - The top ten weighted stocks in the Sci-Tech Chip Index as of June 30, 2025, include SMIC, Haiguang Information, and Cambricon, collectively accounting for 57.76% of the index [4]
链聚科创板
Shang Hai Zheng Quan Bao· 2025-07-21 19:54
Core Insights - The Sci-Tech Innovation Board (STAR Market) has officially launched, with a total market value exceeding 7 trillion yuan, showcasing the emergence of strong industrial clusters in various sectors [1] - Over six years, the STAR Market has fostered 589 "hard tech" listed companies, raising over 1.1 trillion yuan in direct financing, significantly reshaping the innovation ecosystem [1] - The board has successfully transformed over 120,000 invention patents into tangible benefits for society, enhancing public welfare [1] Industry Developments - In the integrated circuit sector, a complete industrial chain covering design, manufacturing, packaging, materials, and equipment has formed, with 120 listed companies leading the way [3] - Major players like SMIC and Huahong Semiconductor have achieved significant milestones, such as breaking international monopolies and reaching international quality standards [3] - The average R&D intensity of integrated circuit companies on the STAR Market is 22.5%, exceeding the industry average by 10 percentage points [3] Biopharmaceutical Sector - The STAR Market's fifth listing standard has opened crucial financing channels for unprofitable innovative drug companies, with 19 out of 20 companies under this standard successfully launching self-developed drugs [4] - Zai Lab, the first unprofitable drug company listed on the STAR Market, has achieved multiple innovative drug approvals, establishing itself as a benchmark for internationalization in drug innovation [4] High-end Equipment Manufacturing - The STAR Market has created a collaborative innovation matrix in high-end equipment manufacturing, with 127 companies covering critical industries such as high-speed rail and nuclear power [5] - China Railway Signal & Communication Corporation holds a 65% market share in high-speed rail signal control systems, ensuring the safety of the national high-speed rail network [5] Social Impact - The technological breakthroughs from the STAR Market have translated into real benefits for the public, significantly reducing drug prices and improving access to medical resources [6] - Innovative drugs have substantially lowered the economic burden on patients, with some treatments seeing price reductions of over 75% [6] - Domestic medical equipment has improved accessibility, with companies like United Imaging Healthcare breaking international monopolies and producing high-end medical devices [7] Financial Performance - Over 60% of STAR Market companies have introduced cash dividend plans, totaling 38.8 billion yuan, with over 290 companies distributing more than 30% of their profits [9] - The board has also seen significant share buyback and increase plans, with a total amount nearing 38 billion yuan [9] Institutional Innovations - The STAR Market has implemented continuous institutional innovations to address the financing challenges of "light asset, high R&D investment" companies, allowing for a higher refinancing ratio [10] - The establishment of the "Sci-Tech Growth Layer" provides a transitional platform for unprofitable tech companies, enhancing their growth prospects [10] Long-term Vision - The STAR Market has become a core nurturing ground for new productive forces, with 379 companies recognized as national "little giants" and 415 as manufacturing "champions" [12] - The board's R&D investment reached 168 billion yuan, more than three times its net profit, reflecting a strong commitment to innovation [12] - The ongoing reforms aim to further unleash the potential of the STAR Market, enhancing its role in both technological advancement and societal value [13]
芯原股份(688521) - 2025年第一次临时股东大会会议材料
2025-07-21 13:00
证券代码:688521 证券简称:芯原股份 芯原微电子(上海)股份有限公司 2025 年第一次临时股东大会会议材料 二〇二五年七月 目 录 | 芯原微电子(上海)股份有限公司 | 年第一次临时股东大会会议须知 2025 | 2 | | --- | --- | --- | | 芯原微电子(上海)股份有限公司 | 2025 年第一次临时股东大会会议议程 | 4 | | 芯原微电子(上海)股份有限公司 | 年第一次临时股东大会会议议案 2025 | 7 | | 议案一 | 关于变更公司注册资本的议案 | 7 | | 议案二 | 关于取消监事会、修订公司章程并办理工商变更登记的议案 | 9 | | 议案三 | 关于修订《股东大会议事规则》的议案 | 10 | | 议案四 | 关于修订《董事会议事规则》的议案 | 11 | | 议案五 | 关于修订《对外投资管理制度》的议案 | 12 | | 议案六 | 关于修订《对外担保管理制度》的议案 | 13 | | 议案七 | 关于修订《关联交易管理制度》的议案 | 14 | | 议案八 | 关于修订《募集资金管理办法》的议案 | 15 | | 议案九 | 关于修订《累积投票制 ...
芯原微电子(上海)股份有限公司关于股份回购事项前十大股东和前十大无限售条件股东持股情况的公告
Shang Hai Zheng Quan Bao· 2025-07-18 20:18
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688521 证券简称:芯原股份 公告编号:2025-037 芯原微电子(上海)股份有限公司 关于股份回购事项前十大股东 和前十大无限售条件股东持股情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 芯原微电子(上海)股份有限公司(以下简称"公司")于2025年7月14日召开第二届董事会第二十三次 会议,审议通过了《关于以集中竞价交易方式回购公司股份方案的议案》。公司全体董事出席会议,以 9票同意、0票反对、0票弃权的表决结果通过了该项议案。具体内容详见公司于2025年7月15日披露的 《关于以集中竞价交易方式回购股份的预案》(公告编号:2025-031)。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一一回购股份》等相关 规定,现将公司董事会披露回购股份决议前一个交易日(即2025年7月14日)登记在册的前十大股东和 前十大无限售条件股东的名称、持股数量及持股比例公告如下: 一、公司前十大股东持股情况 ■ 二、公司前十大无限售条 ...
芯原股份: 关于首次公开发行前股票期权行权限售股上市流通的公告
Zheng Quan Zhi Xing· 2025-07-18 16:23
证券代码:688521 证券简称:芯原股份 公告编号:2025-038 芯原微电子(上海)股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 本次股票上市类型为 股权激励股份 ;股票认购方式为 网下 ,上市股数为 本次股票上市流通总数为1,863,534股。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2020 年 7 月 21 日出具的《关于同意芯原微 电子(上海)股份有限公司首次公开发行股票注册的批复》(证监许可20201537 号),芯原微电子(上海)股份有限公司(以下简称"芯原股份"或"公司")获 准首次向社会公开发行人民币普通股(A 股)股票 48,319,289 股。经上海证券交 易所同意,公司于 2020 年 8 月 18 日在上海证券交易所科创板挂牌上市。公司首 次公开发行完成后,总股本为 483,192,883 股,其中有限售条件流通股为 440,447,482 股,无限售条件流通股为 42,745,401 股。 本次上市流通的限售股为公司 2019 年股票期 ...
7月18日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-18 10:12
Group 1 - Senyuan Electric signed a strategic cooperation agreement with Xuchang Digital Supply Chain Management Co., aiming for annual business cooperation not exceeding 500 million yuan over 36 months [1] - CICC's subsidiary, CICC Wealth, reported a net profit of 987 million yuan for the first half of the year, with total assets of 193.37 billion yuan [2] - Shuangjie Electric expects a net profit of 100 million to 120 million yuan for the first half of the year, representing a year-on-year increase of 16.03% to 39.23% [3][4] - Shentong Technology reported a net profit of 64.28 million yuan for the first half of the year, a year-on-year increase of 111.09% [5] - Suqian Nongfa's net profit for the first half of the year decreased by 27.72% to 213 million yuan [6] Group 2 - Fuan Pharmaceutical expects a net profit decline of 39.95% to 53.81% for the first half of the year, estimating between 100 million to 130 million yuan [8] - Xingwang Yuda anticipates a net loss of 11 million to 21 million yuan for the first half of the year [9] - Pulaike received a new veterinary drug registration certificate for a vaccine aimed at preventing chicken diseases [10] - Yuandong Biological's ephedrine injection received a drug registration certificate for treating low blood pressure during anesthesia [11] - Suqian Liansheng's subsidiary obtained two invention patent certificates [12] Group 3 - Oke Technology signed a 176 million yuan equipment order with Jiangxi Tianhong New Materials [13] - Publishing Media announced the resignation of its chief accountant due to work changes [15] - Zhongxin Co. plans to use 40 million yuan of idle funds for cash management [16] - Huiyun Titanium plans to use up to 58 million yuan of idle convertible bond funds for cash management [18] - Haineng Technology intends to apply for a credit facility of up to 200 million yuan from a bank [20] Group 4 - Jiabiou expects a net profit increase of 57.61% for the first half of the year, estimating around 107 million yuan [21] - Nanjing Gaoke reported a 1185% year-on-year increase in contract sales area for the second quarter [22] - Shuguang Co. received approval for a specific stock issuance application [23] - Huadong Pharmaceutical's subsidiary received approval for a clinical trial of a new drug targeting advanced solid tumors [23] - Quicheng Co. plans to invest 900 million yuan in two new projects [25] Group 5 - Shenlian Biological's vaccine for avian adenovirus received a new veterinary drug registration certificate [26] - Rike Chemical signed a strategic cooperation framework agreement with Dongming Petrochemical [28] - Jincheng Pharmaceutical's subsidiary received a renewed tobacco production license [29] - Magmi Te's stock issuance application was accepted by the Shenzhen Stock Exchange [29] - Zhongyin Securities received approval to issue bonds totaling up to 14 billion yuan [29] Group 6 - Hewei Electric's executives plan to reduce their holdings by a total of 2.24% of the company's shares [44] - Guo Wang Xintong reported a net profit of 266 million yuan for the first half of the year, a decrease of 10.82% [45] - Guo Wang Xintong's subsidiary won a 966 million yuan tender from the State Grid [46] - Jicheng Electronics won contracts worth approximately 83.79 million yuan from the State Grid [48] - Helen Piano is planning a change of control, leading to a temporary stock suspension [48]